Early this morning in Vienna, Austria, the United Nations Commission on Narcotic Drugs (CND) made a historic decision to adopt the World Health Organization’s (WHO) recommendation to remove cannabis and its resin from Schedule IV under the United Nations (UN)...
Read moreIn the wake of the election many patients have questions about the priorities of the incoming Congress. 4.4 million cannabis patients across the country are stuck under conflicting federal and state cannabis policy, with veterans comprising the largest contingent of...
Read moreWhile many 2020 general election results remain a mystery until all votes are counted, voters were clear in expressing their support for all five statewide cannabis ballot initiatives offered this cycle. This continues a trend from 2016, when eight out...
Read moreWith the November general election approaching and Congress looking to wrap up legislative work for the year in December, it is a good time to assess the status of cannabis reform. The 2019-2020 congressional session has certainly provided some hope...
Read moreA national perspective on safe access for students At ASA, our goal is to ensure that every state has sensible cannabis policies that create safe and legal access for all patients. This means we believe that patients who medicate with...
Read moreThe United States Department of Agriculture closed its comment period after requesting information on the establishment of a domestic hemp program. ASA/PFC submitted comments for the 12 questions being asked, which included additional requirements for measurement uncertainty and requiring the...
Read moreEvery year, Americans for Safe Access spends months comparing every medical cannabis program in the United States with the purpose of analyzing what each program is doing well, where it is failing, and how the state program can improve to...
Read moreAn interview with Debbie Churgai by Abby Stoddard, PharmD, MBA on behalf of The Client Centered Network. Oregon is one of the few but growing number of states that have both a medical cannabis program and an adult use (recreational) program,...
Read moreAdapted from The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience (Routledge, 2019) by Michelle Newhart and William Dolphin As with all things involving social controversy, dispute over what to properly call the plant known by the botanical name...
Read moreOn March 23, the Drug Enforcement Administraction (DEA) published a proposed rulemaking—“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes. Americans...
Read moreShare this page
ASA serves our mission with the help and support of many organizations and businesses. Click here to learn more about these amazing allies!
